Research Project · Health, Medicine, Oncology
Clinical Trials Investigated by Dr. Alexander Drilon
Memorial Sloan Kettering Cancer Centerwww.mskcc.org (opens in a new tab)Catalog updated
- Amount
- Not listed
- Program type
- Research Project
- Field
- Health, Medicine, Oncology
- Eligible career stages
- Not listed
About this program
Memorial Sloan Kettering Cancer Center is conducting multiple clinical trials led by Dr. Alexander Drilon, focusing on advanced solid tumors and non-small cell lung cancer. These Phase 1/2 studies investigate the safety, efficacy, and pharmacokinetics of investigational drugs such as BBI-355, EP0031, NVL-520, NVL-655, TPX-0005, and cabozantinib. Eligibility criteria vary by trial, and interested patients should contact MSK for specific details on enrollment and participation requirements.
In FundFit
FundFit names the researchers at your institution who match this program, and shows the eligibility rules and the announcement in full.
Ask for a demo of this program The form opens already filled in.